AMG 513

FDA frees Amgen's phase 1 obesity asset from clinical trial hold
Fierce Biotech
Fri, 05/2/25 - 11:18 am
FDA
Amgen
obesity
clinical trials
AMG 513
Amgen's early-stage obesity asset slapped with FDA hold
Fierce Biotech
Wed, 02/5/25 - 11:27 am
Amgen
FDA
clinical trials
obesity
AMG 513